Athenex, Inc. - stock earnings
Stock symbol ATNX is outdated, potentially delisted? Maybe it is available on other exchange?
ATNX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q4 | -34.2 million USD | 8.6 million USD |
| 2022Q3 | -19.7 million USD | 33.5 million USD |
| 2022Q2 | -32.2 million USD | 31.5 million USD |
| 2022Q1 | -17.4 million USD | 29.7 million USD |
| 2021Q4 | -104.4 million USD | 24.9 million USD |
| 2021Q3 | -36.1 million USD | 32.3 million USD |
| 2021Q2 | -34.3 million USD | 21.9 million USD |
| 2021Q1 | -25.1 million USD | 41.0 million USD |
| 2020Q4 | -49.5 million USD | 21.8 million USD |
| 2020Q3 | -36.8 million USD | 35.5 million USD |
| 2020Q2 | -40.5 million USD | 40.2 million USD |
| 2020Q1 | -19.4 million USD | 46.9 million USD |
| 2019Q4 | -21.7 million USD | 34.4 million USD |
| 2019Q3 | -34.8 million USD | 19.4 million USD |
| 2019Q2 | -32.0 million USD | 22.2 million USD |
| 2019Q1 | -35.2 million USD | 25.3 million USD |
| 2018Q4 | -27.1 million USD | 21.3 million USD |
| 2018Q3 | -46.2 million USD | 18.4 million USD |
| 2018Q2 | -36.9 million USD | 11.6 million USD |
| 2018Q1 | -7.3 million USD | 37.8 million USD |
| 2017Q4 | -28.3 million USD | 14.9 million USD |
| 2017Q3 | -23.3 million USD | 14.0 million USD |
| 2017Q2 | -38.6 million USD | 4.6 million USD |
| 2017Q1 | -41.0 million USD | 4.6 million USD |
| 2016Q4 | -40.1 million USD | 5.1 million USD |
| 2016Q3 | -24.6 million USD | 5.6 million USD |
| 2016Q2 | -12.4 million USD | 5.2 million USD |
| 2016Q1 | -10.6 million USD | 4.6 million USD |
| 2015Q4 | -50.6 million USD | 13.9 million USD |
ATNX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -103.4 million USD | 102.8 million USD |
| 2021 | -199.8 million USD | 120.2 million USD |
| 2020 | -146.2 million USD | 144.4 million USD |
| 2019 | -123.7 million USD | 101.2 million USD |
| 2018 | -117.4 million USD | 89.1 million USD |
| 2017 | -131.2 million USD | 38.0 million USD |
| 2016 | -87.7 million USD | 20.6 million USD |
| 2015 | -50.6 million USD | 13.9 million USD |
| 2014 | -17.7 million USD | 1.2 million USD |
ATNX
Price: $0.20
52 week price:
Earnings Per Share: -1.52 USD
P/E Ratio: -1.42
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 12.1 million
Ebitda: -22.0 millionMarket Capitalization: 2.3 million